These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7833094)

  • 1. Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.
    Sloane JP; Ellman R; Anderson TJ; Brown CL; Coyne J; Dallimore NS; Davies JD; Eakins D; Ellis IO; Elston CW
    Eur J Cancer; 1994; 30A(10):1414-9. PubMed ID: 7833094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the national external quality assessment (EQA) scheme for breast pathology in the UK.
    Rakha EA; Bennett RL; Coleman D; Pinder SE; Ellis IO;
    J Clin Pathol; 2017 Jan; 70(1):51-57. PubMed ID: 27406051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology.
    Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Eusebi V; De Miguel C; Dervan P; Drijkoningen R; Elston CW; Faverly D; Gad A; Jacquemier J; Lacerda M; Martinez-Penuela J; Munt C; Peterse JL; Rank F; Sylvan M; Tsakraklides V; Zafrani B
    Virchows Arch; 1999 Jan; 434(1):3-10. PubMed ID: 10071228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a national external quality assessment scheme for breast pathology in the UK.
    Ellis IO; Coleman D; Wells C; Kodikara S; Paish EM; Moss S; Al-Sam S; Anderson N; Bobrow L; Buley I; Connolly CE; Dallimore NS; Hales S; Hanby A; Humphreys S; Knox F; Lowe J; Macartney J; Nash R; Parham D; Patnick J; Pinder SE; Quinn CM; Robertson AJ; Shrimankar J; Walker RA; Winder R
    J Clin Pathol; 2006 Feb; 59(2):138-45. PubMed ID: 16443727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology.
    Elston CW; Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Dervan P; Drijkoningen M; Eusebi V; Faverly D; Holland R; Jacquemier J; Lacerda M; Martinez-Penuela J; de Miguel C; Mossi S; Munt C; Peterse JL; Rank F; Reiner A; Sylvan M; Wells CA; Zafrani B
    Eur J Cancer; 2000 Sep; 36(14):1769-72. PubMed ID: 10974624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ductal hyperplasia and ductal carcinoma in situ. Definition--classification--differential diagnosis].
    Böcker W; Decker T; Ruhnke M; Schneider W
    Pathologe; 1997 Jan; 18(1):3-18. PubMed ID: 9157402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observer variability in reporting of breast lesions.
    Beck JS
    J Clin Pathol; 1985 Dec; 38(12):1358-65. PubMed ID: 3001153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme.
    Rakha EA; Ahmed MA; Aleskandarany MA; Hodi Z; Lee AH; Pinder SE; Ellis IO
    Histopathology; 2017 Mar; 70(4):632-642. PubMed ID: 28028831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary carcinoma of the breast: diagnostic agreement and management implications.
    Rakha EA; Ahmed MA; Ellis IO
    Histopathology; 2016 Nov; 69(5):862-870. PubMed ID: 27270947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypia in breast pathology: what pathologists need to know.
    Katayama A; Toss MS; Parkin M; Ellis IO; Quinn C; Rakha EA
    Pathology; 2022 Feb; 54(1):20-31. PubMed ID: 34872753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
    Goldstein NS; O'Malley BA
    Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ. Part I: Definition and diagnosis.
    Delaney G; Ung O; Bilous M; Cahill S; Greenberg M; Boyages J
    Aust N Z J Surg; 1997; 67(2-3):81-93. PubMed ID: 9068547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.
    Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Dervan P; Eusebi V; De Miguel C; Drijkoningen M; Elston CW; Faverley D; Gad A; Jacquemier J; Lacerda M; Martinez-Penuela J; Munt C; Peterse JL; Rank F; Sylvan M; Tsakraklides V; Zafrani B
    Hum Pathol; 1998 Oct; 29(10):1056-62. PubMed ID: 9781641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
    Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW
    Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance in breast cancer screening cytology: a review of the literature and a report on the U.K. national cytology scheme.
    Wells CA
    Eur J Cancer; 1995; 31A(2):273-80. PubMed ID: 7718337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.